MSCs-derived apoptotic extracellular vesicles promote muscle regeneration by inducing Pannexin 1 channel-dependent creatine release by myoblasts

Abstract

Severe muscle injury is hard to heal and always results in a poor prognosis. Recent studies found that extracellular vesicle-based therapy has promising prospects for regeneration medicine, however, whether extracellular vesicles have therapeutic effects on severe muscle injury is still unknown. Herein, we extracted apoptotic extracellular vesicles derived from mesenchymal stem cells (MSCs-ApoEVs) to treat cardiotoxin induced tibialis anterior (TA) injury and found that MSCs-ApoEVs promoted muscles regeneration and increased the proportion of multinucleated cells. Besides that, we also found that apoptosis was synchronized during myoblasts fusion and MSCs-ApoEVs promoted the apoptosis ratio as well as the fusion index of myoblasts. Furthermore, we revealed that MSCs-ApoEVs increased the relative level of creatine during myoblasts fusion, which was released via activated Pannexin 1 channel. Moreover, we also found that activated Pannexin 1 channel was highly expressed on the membrane of myoblasts-derived ApoEVs (Myo-ApoEVs) instead of apoptotic myoblasts, and creatine was the pivotal metabolite involved in myoblasts fusion. Collectively, our findings firstly revealed that MSCs-ApoEVs can promote muscle regeneration and elucidated that the new function of ApoEVs as passing inter-cell messages through releasing metabolites from activated Pannexin 1 channel, which will provide new evidence for extracellular vesicles-based therapy as well as improving the understanding of new functions of extracellular vesicles.

References

[1] Wang YH, Wang DR, Guo YC, Liu JY, Pan J. The application of bone marrow mesenchymal stem cells and biomaterials in skeletal muscle regeneration. Regen. Ther., 2020, 15: 285-294.

[2] Frontera WR, Ochala J. Skeletal muscle: a brief review of structure and function. Calcif. Tissue Int, 2015, 96: 183-195.

[3] Qazi TH, . Cell therapy to improve regeneration of skeletal muscle injuries. J. Cachexia Sarcopenia Muscle, 2019, 10: 501-516.

[4] Dalle S, . Cardiotoxin-induced skeletal muscle injury elicits profound changes in anabolic and stress signaling, and muscle fiber type composition. J. Muscle Res. Cell Motil., 2020, 41: 375-387.

[5] Sartori R, Romanello V, Sandri M. Mechanisms of muscle atrophy and hypertrophy: implications in health and disease. Nat. Commun., 2021, 12: 330-330.

[6] Powers SK, Lynch GS, Murphy KT, Reid MB, Zijdewind I. Disease-induced skeletal muscle atrophy and fatigue. Med. Sci. Sports Exerc., 2016, 48: 2307-2319.

[7] Klebuc M, Menn Z. Muscle flaps and their role in limb salvage. Methodist Debakey Cardiovasc. J., 2013, 9: 95-99.

[8] Sassoli C, . Bone marrow mesenchymal stromal cells stimulate skeletal myoblast proliferation through the paracrine release of VEGF. PLoS One, 2012, 7: e37512.

[9] von Roth P, . Intra-arterial MSC transplantation restores functional capacity after skeletal muscle trauma. Open Orthop. J., 2012, 6: 352-356.

[10] Qiu X, . Mesenchymal stem cells and extracellular matrix scaffold promote muscle regeneration by synergistically regulating macrophage polarization toward the M2 phenotype. Stem Cell Res Ther., 2018, 9: 88.

[11] Gu W, . Smooth muscle cells differentiated from mesenchymal stem cells are regulated by microRNAs and suitable for vascular tissue grafts. J. Biol. Chem., 2018, 293: 8089-8102.

[12] Caplan AI, Correa D. The MSC: an injury drugstore. Cell Stem Cell, 2011, 9: 11-15.

[13] Galleu, A. et al. Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation. Sci. Transl. Med. 9, eaam7828 (2017).

[14] Weiss ARR, Dahlke MH. Immunomodulation by Mesenchymal Stem Cells (MSCs): mechanisms of action of living, apoptotic, and dead MSCs. Front. Immunol., 2019, 10: 1191-1191.

[15] Sebbagh M, . Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing. Nat. Cell Biol., 2001, 3: 346-352.

[16] Saraste A, Pulkki K. Morphologic and biochemical hallmarks of apoptosis. Cardiovascular Res., 2000, 45: 528-537.

[17] Liu D, . Circulating apoptotic bodies maintain mesenchymal stem cell homeostasis and ameliorate osteopenia via transferring multiple cellular factors. Cell Res., 2018, 28: 918-933.

[18] Liu H, . Donor MSCs release apoptotic bodies to improve myocardial infarction via autophagy regulation in recipient cells. Autophagy, 2020, 16: 2140-2155.

[19] Liu J, . Apoptotic bodies derived from mesenchymal stem cells promote cutaneous wound healing via regulating the functions of macrophages. Stem Cell Res. Ther., 2020, 11: 507.

[20] Zheng C, . Apoptotic vesicles restore liver macrophage homeostasis to counteract type 2 diabetes. J. Extracell. Vesicles, 2021, 10: e12109.

[21] Atkin-Smith GK, . A novel mechanism of generating extracellular vesicles during apoptosis via a beads-on-a-string membrane structure. Nat. Commun., 2015, 6: 7439-7439.

[22] Deldicque L, . Creatine enhances differentiation of myogenic C2C12 cells by activating both p38 and Akt/PKB pathways. Am. J. Physiol. Cell Physiol., 2007, 293: C1263-C1271.

[23] Farshidfar F, Pinder MA, Myrie SB. Creatine supplementation and skeletal muscle metabolism for building muscle mass—review of the potential mechanisms of action. Curr. Protein Pept. Sci., 2017, 18: 1273-1287.

[24] Chiu Y-H, . A quantized mechanism for activation of pannexin channels. Nat. Commun., 2017, 8

[25] Narahari AK, . ATP and large signaling metabolites flux through caspase-activated Pannexin 1 channels. Elife, 2021, 10: e64787.

[26] Zeng C, Shao Z, Li J, Pan H, Xing F. Commentary: Metabolites released from apoptotic cells act as tissue messengers. Front. Immunol., 2020, 11: 1878.

[27] Wang J, Jackson DG, Dahl G. The food dye FD&C Blue No. 1 is a selective inhibitor of the ATP release channel Panx1. J. Gen. Physiol., 2013, 141: 649-656.

[28] Beckel JM, . Pannexin 1 channels mediate the release of ATP into the lumen of the rat urinary bladder. J. Physiol., 2015, 593: 1857-1871.

[29] King KL, Cidlowski JA. Cell cycle regulation and apoptosis. Annu Rev. Physiol., 1998, 60: 601-617.

[30] Kerr JF. History of the events leading to the formulation of the apoptosis concept. Toxicology, 2002, 181–182: 471-474.

[31] Bosurgi L, . Macrophage function in tissue repair and remodeling requires IL-4 or IL-13 with apoptotic cells. Science, 2017, 356: 1072-1076.

[32] Pérez-Garijo A, Steller H. Spreading the word: non-autonomous effects of apoptosis during development, regeneration and disease. Development, 2015, 142: 3253-3262.

[33] Guerin DJ, Kha CX, Tseng KA-S. From cell death to regeneration: rebuilding after injury. Front. Cell Develop. Biol., 2021, 9: 655048-655048.

[34] Hochreiter-Hufford AE, . Phosphatidylserine receptor BAI1 and apoptotic cells as new promoters of myoblast fusion. Nature, 2013, 497: 263-267.

[35] Park S-Y, . Stabilin-2 modulates the efficiency of myoblast fusion during myogenic differentiation and muscle regeneration. Nat. Commun., 2016, 7

[36] Cheng, L. & Hill, A. F. Therapeutically harnessing extracellular vesicles. Nat. Rev. Drug Discov. 21, 379–399 (2022).

[37] van Niel G, D’Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat. Rev. Mol. Cell Biol., 2018, 19: 213-228.

[38] Elsharkasy OM, . Extracellular vesicles as drug delivery systems: why and how?. Adv. Drug Deliv. Rev., 2020, 159: 332-343.

[39] de Jong OG, . Drug delivery with extracellular vesicles: from imagination to innovation. Acc. Chem. Res., 2019, 52: 1761-1770.

[40] Caruso S, Poon IKH. Apoptotic cell-derived extracellular vesicles: more than just debris. Front Immunol., 2018, 9: 1486.

[41] Medina CB, . Metabolites released from apoptotic cells act as tissue messengers. Nature, 2020, 580: 130-135.

[42] Weilinger NL, . Metabotropic NMDA receptor signaling couples Src family kinases to pannexin-1 during excitotoxicity. Nat. Neurosci., 2016, 19: 432-442.

[43] Chekeni FB, . Pannexin 1 channels mediate ‘find-me’ signal release and membrane permeability during apoptosis. Nature, 2010, 467: 863-867.

[44] Sandilos JK, . Pannexin 1, an ATP release channel, is activated by caspase cleavage of its pore-associated C-terminal autoinhibitory region. J. Biol. Chem., 2012, 287: 11303-11311.

[45] Poon IK, . Unexpected link between an antibiotic, pannexin channels and apoptosis. Nature, 2014, 507: 329-334.

[46] Imamura, H. et al. Single-cell dynamics of pannexin-1-facilitated programmed ATP loss during apoptosis. Elife 9, e61960 (2020).

[47] Xie F, . Role of MicroRNA, LncRNA, and exosomes in the progression of osteoarthritis: a review of recent literature. Orthop. Surg., 2020, 12: 708-716.

[48] Zernecke A, . Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci. Signal, 2009, 2: ra81.

[49] Huang S, . An improved protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow. J. Orthop. Transl., 2015, 3: 26-33.

[50] Grounds MD, Radley HG, Lynch GS, Nagaraju K, De Luca A. Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy. Neurobiol. Dis., 2008, 31: 1-19.

[51] Mou L, . Structural basis for gating mechanism of Pannexin 1 channel. Cell Res., 2020, 30: 452-454.

Funding

National Natural Science Foundation of China (National Science Foundation of China)(32101096, 32100953, 2021YFA1100600, 82170955)

Natural Science Foundation of Shaanxi Provincial Department of Education (Natural Science Foundation of Shaanxi Provincial Education Department)(2022SF-095)